Idarucizumab Resistance Due to a Markedly Elevated Dabigatran Concentration – A Case Report
Pathology - United States
doi 10.1016/j.pathol.2020.01.372
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
Elsevier BV